Hospital staff antibody study reveals vaccine response over time
NCT ID NCT04939402
First seen Jan 09, 2026 · Last updated May 01, 2026 · Updated 21 times
Summary
This study measures how many hospital employees developed COVID-19 antibodies after receiving the AstraZeneca vaccine. Researchers will test 200 workers at 6 weeks, 6 months, and 12 months after their second shot. The goal is to understand how long vaccine protection may last.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UZ Brussel
Brussels, 1090, Belgium
Conditions
Explore the condition pages connected to this study.